NDC 65862-767

FESOTERODINE FUMARATE

Fesoterodine Fumarate

FESOTERODINE FUMARATE is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Fesoterodine Fumarate.

Product ID65862-767_dc8f6158-3c2b-4ec0-a951-e04468b83bb1
NDC65862-767
Product TypeHuman Prescription Drug
Proprietary NameFESOTERODINE FUMARATE
Generic NameFesoterodine Fumarate
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2022-06-17
Marketing CategoryANDA /
Application NumberANDA205007
Labeler NameAurobindo Pharma Limited
Substance NameFESOTERODINE FUMARATE
Active Ingredient Strength8 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65862-767-30

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-767-30)
Marketing Start Date2022-06-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FESOTERODINE FUMARATE" or generic name "Fesoterodine Fumarate"

NDCBrand NameGeneric Name
43598-247Fesoterodine fumarateFesoterodine fumarate
43598-248Fesoterodine fumarateFesoterodine fumarate
65862-766FESOTERODINE FUMARATEFESOTERODINE FUMARATE
65862-767FESOTERODINE FUMARATEFESOTERODINE FUMARATE
67877-064Fesoterodine FumarateFesoterodine Fumarate
67877-068Fesoterodine FumarateFesoterodine Fumarate
68382-479fesoterodine fumaratefesoterodine fumarate
68382-480fesoterodine fumaratefesoterodine fumarate
70771-1168fesoterodine fumaratefesoterodine fumarate
70771-1169fesoterodine fumaratefesoterodine fumarate
0069-0242Toviazfesoterodine fumarate
0069-0244Toviazfesoterodine fumarate
55154-2737Toviazfesoterodine fumarate
55154-2738Toviazfesoterodine fumarate
63539-183Toviazfesoterodine fumarate
63539-242Toviazfesoterodine fumarate

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.